India is seeing a sharp rise in demand for obesity and diabetes medications.
But this trend says more about lifestyle than medicine.

Drugs like GLP-1 agonists are helping people manage weight and blood sugar,
yet experts warn they aren’t a substitute for long-term habits.

The real concern?
Rising cases of obesity, prediabetes and Type 2 diabetes, even among younger adults.

The message is clear:
Medication can support, but prevention still starts with lifestyle.

Follow @diabesmartindia for more insights on India’s metabolic health trends.